Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Skarbnik

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Opinion in Hematology|September 5, 2019
Current landscape for chimeric antigen receptor T cells in lymphomasAlan P Skarbnik
Therapeutic Advances in Hematology|March 2, 2017
The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversiesAlan P Skarbnik, Stefan Faderl
Expert Review of Hematology|February 5, 2013
Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphomaAlan P Skarbnik, Barbara Pro
Best Practice & Research. Clinical Haematology|June 13, 2012
Radioimmunotherapy in mantle cell lymphomaAlan P Skarbnik, Mitchell R Smith
Translational Lung Cancer Research|March 26, 2015
Does the order of factors affect the product? Lessons learned from the TORCH trialAlan P Skarbnik, Anthony J Olszanski
Clinical Advances in Hematology & Oncology : H&O|February 14, 2015
Mantle cell lymphoma: state of the artAlan P Skarbnik, Andre H Goy
Discovery Medicine|April 3, 2013
Therapies for mantle cell lymphoma: current challenges and a brighter futureAlan P Skarbnik, Mitchell R Smith
Expert Review of Hematology|May 9, 2015
Lenalidomide for mantle cell lymphomaAlan P Skarbnik, Andre H Goy
Frontiers in Oncology|June 12, 2013
Peripheral T-cell lymphomas: a review of current approaches and hopes for the futureAlan P Skarbnik, Meher Burki, Barbara Pro
Expert Review of Hematology|March 10, 2017
Targeting indolent non-Hodgkin lymphomaLori A Leslie, Alan P Skarbnik, Coleen Bejot, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Opinion in Hematology|September 5, 2019
Current landscape for chimeric antigen receptor T cells in lymphomasAlan P Skarbnik
Therapeutic Advances in Hematology|March 2, 2017
The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversiesAlan P Skarbnik, Stefan Faderl
Expert Review of Hematology|February 5, 2013
Heads or tails? Choosing a salvage therapy for relapsed/refractory Hodgkin lymphomaAlan P Skarbnik, Barbara Pro
Best Practice & Research. Clinical Haematology|June 13, 2012
Radioimmunotherapy in mantle cell lymphomaAlan P Skarbnik, Mitchell R Smith
Translational Lung Cancer Research|March 26, 2015
Does the order of factors affect the product? Lessons learned from the TORCH trialAlan P Skarbnik, Anthony J Olszanski
Clinical Advances in Hematology & Oncology : H&O|February 14, 2015
Mantle cell lymphoma: state of the artAlan P Skarbnik, Andre H Goy
Discovery Medicine|April 3, 2013
Therapies for mantle cell lymphoma: current challenges and a brighter futureAlan P Skarbnik, Mitchell R Smith
Expert Review of Hematology|May 9, 2015
Lenalidomide for mantle cell lymphomaAlan P Skarbnik, Andre H Goy
Frontiers in Oncology|June 12, 2013
Peripheral T-cell lymphomas: a review of current approaches and hopes for the futureAlan P Skarbnik, Meher Burki, Barbara Pro
Expert Review of Hematology|March 10, 2017
Targeting indolent non-Hodgkin lymphomaLori A Leslie, Alan P Skarbnik, Coleen Bejot, et al.
Pageof 4